Growth factor mutants with improved biological activity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9012401
APP PUB NO 20080260830A1
SERIAL NO

11817735

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to novel biosynthetic growth factor mutants which exhibit improved biological activity.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA MBH;CHARITE-UNIVERSITATSMEDIZIN BERLIN;FREIE UNIVERSITAT BERLIN;BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLGISCHEN ENTWICKLUNG VON PHARMAKA MBH

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Knaus, Petra Berlin, DE 3 14
Kruse, Michael Mainz, DE 27 174
Mundlos, Stefan Berlin, DE 5 1
Plöger, Frank Wiesbaden, DE 6 17
Pohl, Jens Hambrücken, DE 135 1803

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 21, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00